About
Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Based on a field of science called Stochastic Resonance, our precise and gentle stimulation improves breathing rhythm and lung function in newborns. Since 2017, we've received over $8M in awards and grants funding the clinical evaluation of our therapy to improve the treatment of opioid-exposed newborns and preterm infants with apnea of prematurity. Next, we aim to improve the treatment of preterm intermittent hypoxemia and bronchopulmonary dysplasia. For more information, visit prapela.com
Technologies
GmailGoogle AppsGoogle Cloud HostingVarnishMobile FriendlyWixNode.jsAndroidCircleRemoteRenderAIIoT
Keywords
medical devicepediatricsneonatologyneonatal intensive caretherapyapnea of prematurityneonatal abstinence syndromeintermittenty hypoxemiahypoxianeonatal incubatorsinfant sleeprespiratory synctial virusmedical equipment manufacturingneonatal health improvementapnea reduction devicefda-authorized medical deviceneonatal apnea treatmentmedical equipment and supplies manufacturingnon-pharmacological therapymedical device grantsstochastic resonanceinfant sleep cycle supportneonatal carefda breakthrough deviceneonatal health researchneonatal therapy deviceneonatal treatment technologystochastic vibrotactile stimulationinfant care equipmentneonatal treatment device
Company Information
- Employees3
- Founded2017
- Total Funding$3700000
Location
2 Monument Sq, Portland, Maine, United States, 04101-4032
